A dynamic view of molecular switch behavior at serotonin receptors: Implications for Functional selectivity

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Martí Solano, Maria ^a   Sanz, Ferran ^a   Pastor, Manuel ^a   Selent, Jana ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ERGOTAMINE; SEROTONIN 1B RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN AGONIST;

ARTICLE; BINDING SITE; CONTROLLED STUDY; FUNCTIONAL SELECTIVITY; HYDROPHOBICITY; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; X RAY ANALYSIS; CHEMICAL PHENOMENA; CHEMISTRY; METABOLISM; PROTEIN DATABASE; PROTEIN TERTIARY STRUCTURE; THERMODYNAMICS;

BINDING SITES; DATABASES, PROTEIN; ERGOTAMINE; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MOLECULAR DYNAMICS SIMULATION; PROTEIN STABILITY; PROTEIN STRUCTURE, TERTIARY; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTOR, SEROTONIN, 5-HT2B; SEROTONIN RECEPTOR AGONISTS; THERMODYNAMICS;

EID: 84908031988     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109312     Document Type: Article

References (42)

1. Urban J, Clarke W, von Zastrow M, Nichols DE, Kobilka B, et al. (2007) Functional selectivity and classical concepts of quantitative pharmacology. J Pharmacol Exp Ther 320:1-13.
2. Martí-Solano M, Guixà-González R, Sanz F, Pastor M, Selent J (2013) Novel Insights into Biased Agonism at G Protein-Coupled Receptors and their Potential for Drug Design. Curr Pharm Des 19:5156-5166.
3. Wisler JW, Xiao K, Thomsen AR, Lefkowitz RJ (2014) Recent developments in biased agonism. Curr Opin Cell Biol 27C: 18-24.
4. Kenakin T, Christopoulos A (2012) Signalling bias in new drug discovery: detection, quantification and therapeutic impact. Nat Rev Drug Discov 12:205-216.
5. Allen JA, Yost JM, Setola V, Chen X, Sassano MF, et al. (2011) Discovery of beta-Arrestin-Biased Dopamine D2 Ligands for Probing Signal Transduction Pathways Essential for Antipsychotic Efficacy. Proc Natl Acad Sci U S A. 108:2-7.
6. Park P S H (2012) Ensemble of G Protein-Coupled Receptor Active States. Curr Med Chem. 19:1146-1154.
7. Kenakin T, Miller LJ (2010) Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol Rev. 62:265-304.
8. Preininger AM, Meiler J, Hamm HE (2013) Conformational flexibility and structural dynamics in GPCR-mediated G protein activation: a perspective. J Mol Biol. 425:2288-2298.
9. Wang C, Jiang Y, Ma J, Wu H, Wacker D, et al. (2013) Structural Basis for Molecular Recognition at Serotonin Receptors. Science. 340:610-614.
10. Wacker D, Wang C, Katritch V, Han G (2013) Structural Features for Functional Selectivity at Serotonin Receptors. Science. 340:615-619.
11. Labruijere S, Villalo CM, Vandenbrink AM (2013) Activation of 5-hydrozytryptamine1B/1D/1F receptors as a mechanism of action of antimigraine drugs. Expert Opin Pharmacother. 14:1599-1610.
12. Roth B (2007) Drugs and valvular heart disease. N Engl J Med: 6-9.
13. Nygaard R, Frimurer TM, Holst B, Rosenkilde MM, Schwartz TW (2009) Ligand binding and micro-switches in 7TM receptor structures. Trends Pharmacol Sci. 30:249-259.
14. Harvey MJ, De Fabritiis G (2012) High-throughput molecular dynamics: the powerful new tool for drug discovery. Drug Discov Today. 17:1059-1062.
15. Dror RO, Arlow DH, Maragakis P, Mildorf TJ, Pan AC, et al. (2011) Activation mechanism of the b2-adrenergic receptor. Proc Natl Acad Sci U S A. 108:1-6.
16. Nygaard R, Zou Y, Dror RO, Mildorf TJ, Arlow DH, et al. (2013) The Dynamic Process of b2-Adrenergic Receptor Activation. Cell. 152:532-542.
17. Kruse AC, Hu J, Pan AC, Arlow DH, Rosenbaum DM, et al. (2012) Structure and dynamics of the M3 muscarinic acetylcholine receptor. Nature. 482:552-556.
18. Dror RO, Pan AC, Arlow DH, Borhani DW, Maragakis P, et al. (2011) Pathway and mechanism of drug binding to G-protein-coupled receptors. Proc Natl Acad Sci U S A. 108:13118-13123.
19. Ballesteros J, Weinstein H (1995) Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors. Methods Neurosci. 25:366-428.
20. Rasmussen S G F, DeVree BT, Zou Y, Kruse AC, Chung KY, et al. (2011) Crystal structure of the beta2 adrenergic receptor-Gs protein complex. Nature. 477:549-555.
21. Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen S G F, Thian FS, et al. (2007) High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science. 318:1258-1265.
22. Ballesteros JA, Jensen AD, Liapakis G, Rasmussen SG, Shi L, et al. (2001) Activation of the beta 2-adrenergic receptor involves disruption of an ionic lock between the cytoplasmic ends of transmembrane segments 3 and 6. J Biol Chem. 276:29171-29177.
23. Yuan S, Ghoshdastider U, Trzaskowski B, Latek D, Debinski A, et al. (2012) The role of water in activation mechanism of human N-formyl peptide receptor 1 (FPR1) based on molecular dynamics simulations. PLoS One. 7:e47114.
24. Dror RO, Arlow DH, Maragakis P, Mildorf TJ, Pan AC, et al. (2011) Activation mechanism of the b2-adrenergic receptor. Proc Natl Acad Sci U S A. 108:18684-18689.
25. Bock A, Merten N, Schrage R, Dallanoce C, Bätz J, et al. (2012) The allosteric vestibule of a seven transmembrane helical receptor controls G-protein coupling. Nat Commun. 3:1044.
26. Gregory KJ, Hall NE, Tobin AB, Sexton PM, Christopoulos A (2010) Identification of orthosteric and allosteric site mutations in M2 muscarinic acetylcholine receptors that contribute to ligand-selective signaling bias. J Biol Chem. 285:7459-7474.
27. Venkatakrishnan AJ, Deupi X, Lebon G, Tate CG, Schertler GF, et al. (2013) Molecular signatures of G-protein-coupled receptors. Nature. 494:185-194.
28. Katritch V, Cherezov V, Stevens R (2013) Structure-function of the G proteincoupled receptor superfamily. Annu Rev Pharmacol Toxicol: 531-556.
29. Li H, Robertson AD, Jensen JH (2005) Very fast empirical prediction and rationalization of protein pKa values. Proteins. 61:704-721.
30. Chemical Computing Group (2014) Molecular Operating Environment (MOE) software. Available: http://www.chemcomp.com/software.htm. Accessed 2014 Sep. 25.
31. Jo S, Lim JB, Klauda JB, Im W (2009) CHARMM-GUI Membrane Builder for mixed bilayers and its application to yeast membranes. Biophys J. 97:50-58.
32. Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph. 14:33-38.
33. Case D (2012) AMBER 12. Amber Molecular Dynamics software. Available: http://ambermd.org/. Accessed 2014 Sep. 25.
34. Harvey MJ, Giupponi G, De Fabritiis G (2009) ACEMD: Accelerating Biomolecular Dynamics in the Microsecond Timescale. J Chem Theory Comput. 5:1632-1639.
35. Feenstra KA (1999) Improving efficiency of large time-scale molecular dynamics simulations of hydrogen-rich systems. J Comput Chem. 20:786-798.
36. Bonomi M, Branduardi D, Bussi G, Camilloni C, Provasi D, et al. (2009) PLUMED: a portable plugin for free-energy calculations with molecular dynamics: 1-15.
37. Barducci A, Bussi G, Parrinello M (2008) Well-Tempered Metadynamics: A Smoothly Converging and Tunable Free-Energy Method. Phys Rev Lett. 100:020603.
38. Raiteri P, Laio A, Gervasio FL, Micheletti C, Parrinello M (2006) Efficient Reconstruction of Complex Free Energy Landscapes by Multiple Walkers Metadynamics. J Phys Chem B. 110:3533-3539.
39. R Core Team (2014) R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing. Available: http://www. R-project.org/. Accessed 2014 Sep. 25.
40. Williams T, Kelly C (2014) Gnuplot 4.5: an interactive plotting program. Available: http://www.gnuplot.info/. Accessed 2014 Sep. 25.
41. Mezei M, Filizola M (2006) TRAJELIX: a computational tool for the geometric characterization of protein helices during molecular dynamics simulations. J Comput Aided Mol Des. 20:97-107.
42. Mezei M (2010) Simulaid: a simulation facilitator and analysis program. J Comput Chem: 2658-2668.